tment Evaluation Units (VTEUs) studying the H7N9 candidate vaccine. In addition to the University of Maryland, VTEU sites are Baylor College of Medicine, Houston; Children's Hospital Medical Center, Cincinnati; Group Health Cooperative, Seattle; Saint Louis University, St. Louis; University of Iowa, Iowa City; Emory University, Atlanta; and Vanderbilt University, Nashville. Additionally, the University of Texas Medical Branch in Galveston will be conducting the trial as a subcontractor to Baylor College of Medicine.
For more information about participating in clinical trials at the Center for Vaccine Development, please call 410-706-6156 or visit www.clinicaltrials.gov , using the identifiers: NCT01938742 and NCT01942265.
About the University of Maryland School of Medicine
Established in 1807, the University of Maryland School of Medicine is the first public medical school in the United States, the first to institute a residency-training program. The School of Medicine was the founding school of the University of Maryland and today is an integral part of the 11-campus University System of Maryland. On the University of Maryland's Baltimore campus, the School of Medicine serves as the anchor for a large academic health center which aims to provide the best medical education, conduct the most innovative biomedical research and provide the best patient care and community service to Maryland and beyond.